Department of Biomedical Engineering
Corporate
Industry is a full partner in Biomedical Engineering. The Executive Advisory Board was formed in 1999 and is comprised of senior executives representing a range from start-up to major biomedical device and diagnostics companies, venture capital, consulting firms, and professional service providers. The board meets quarterly to assist academic leadership several ways.
Curriculum Development
- The Board advises UCI on its strong interest in the establishment of a biomedical engineering minor and new specializations to complement the major at the undergraduate level. Industry sponsorship of specific project assignments in new design and independent study courses has been implemented with reassurance that proprietary rights waivers by students are appropriate where warranted by the subject matter.
Student Internships and Continuing Education
- In addition to the curriculum development and course project sponsorship described above, the Executive Advisory Board is a full partner in developing customized summer internship experiences to ensure that the workforce remains current with rapid technology advances affecting their operations. Collaboration between the Biomedical Engineering Department and other offices within UCI (e.g. University Extension) will be an important element of the industry-university partnership as the program evolves.
Access to UCI Facilities and Resources
- The Samueli School of Engineering is committed to the establishment of state-of-the-art facilities to support both faculty and industry research and prototyping requirements. The Executive Advisory Board will serve as a liaison between local industry and core facilities. The equipment and facilities also represent important resources for biomedical companies, as does access to the faculty for consulting purposes.
Technology Transfer
- Research collaborations between biomedical device, diagnostics and related computational companies and the faculty at UCI are expected to result in increased numbers of discoveries and commercial products, which are fundamental to the vision of the BME Department. The Research Translation Group at UC Irvine Beall Applied Innovation establishes guidelines for this process.
Current Members
Michelle Digman
UC Irvine
Bill Link
Versant Ventures
David Cuccia
Modulim
Stanton Rowe
Nidus Biomedical
Kenny Dang
Terumo Neuro
Vasudev Bailey
Hologen
Thomas Navratil
Glaukos Corporation
John Wainwright
Acandis GmbH